Brain metastasis magnetic resonance imaging-based deep learning for predicting epidermal growth factor receptor (EGFR) mutation and subtypes in metastatic non-small cell lung cancer

被引:1
|
作者
Cao, Ran [1 ,2 ]
Fu, Langyuan [1 ]
Huang, Bo [3 ]
Liu, Yan [1 ]
Wang, Xiaoyu [4 ]
Liu, Jiani [4 ]
Wang, Haotian [4 ]
Jiang, Xiran [1 ]
Yang, Zhiguang [5 ]
Sha, Xianzheng [1 ]
Zhao, Nannan [4 ]
机构
[1] China Med Univ, Sch Intelligent Med, 77 Puhe Rd, Shenyang 110122, Peoples R China
[2] Fudan Univ, Sch Informat Sci & Technol, Dept Biomed Engn, Shanghai, Peoples R China
[3] China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Pathol, Shenyang, Peoples R China
[4] China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Radiol, 44 Xiaoheyan Rd, Shenyang 110042, Peoples R China
[5] China Med Univ, Shengjing Hosp, Dept Radiol, 36 Sanhao St, Shenyang 110004, Peoples R China
基金
国家重点研发计划;
关键词
Brain metastases (BM); epidermal growth factor receptor (EGFR); EGFR ); deep learning; non-small cell lung cancer (NSCLC); radiomics; OPEN-LABEL; EXON; 19; MUTANT; SURVIVAL; RESISTANCE; BIOMARKER; 1ST-LINE; IMAGES;
D O I
10.21037/qims-23-1744
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The preoperative identification of epidermal growth factor receptor ( EGFR ) mutations and subtypes based on magnetic resonance imaging (MRI) of brain metastases (BM) is necessary facilitate individualized therapy. This study aimed to develop a deep learning model to preoperatively detect EGFR mutations and identify the location of EGFR mutations in patients with non-small cell lung cancer (NSCLC) and BM. Methods: We included 160 and 72 patients who underwent contrast-enhanced T1-weighted (T1w-CE) and T2-weighted (T2W) MRI at Liaoning Cancer Hospital and Institute (center 1) and Shengjing Hospital China Medical University (center 2) to form a training cohort and an external validation cohort, respectively. A multiscale feature fusion network (MSF-Net) was developed by adaptively integrating features based different stages of residual network (ResNet) 50 and by introducing channel and spatial attention modules. The external validation set from center 2 was used to assess the performance of MSF-Net and to compare it with that of handcrafted radiomics features. Receiver operating characteristic (ROC) curves, accuracy, precision, recall, and F1-score were used to evaluate the effectiveness of the models. Gradient-weighted class activation mapping (Grad-CAM) was used to demonstrate the attention of the MSF-Net model. Results: The developed MSF-Net generated a better diagnostic performance than did the handcrafted radiomics in terms of the microaveraged area under the curve (AUC) (MSF-Net: 0.91; radiomics: 0.80) and macroaveraged AUC (MSF-Net: 0.90; radiomics: 0.81) for predicting EGFR mutations and subtypes. Conclusions: This study provides an end-to-end and noninvasive imaging tool for the preoperative prediction of EGFR mutation status and subtypes based on BM, which may be helpful for facilitating individualized clinical treatment plans.
引用
收藏
页码:4749 / 4762
页数:14
相关论文
共 50 条
  • [31] Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer
    Zhang, Liwen
    Chen, Bojiang
    Liu, Xia
    Song, Jiangdian
    Fang, Mengjie
    Hu, Chaoen
    Dong, Di
    Li, Weimin
    Tian, Jie
    TRANSLATIONAL ONCOLOGY, 2018, 11 (01): : 94 - 101
  • [32] Analysis of metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
    Chen, Yu
    Deng, Juan
    Liu, Yu
    Wang, Hao
    Zhao, Sha
    He, Yayi
    Zhou, Caicun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [33] Mutation of Epidermal Growth Factor Receptor (EGFR) in Patients with Non-Small Cell Lung Cancer (NSCLC) in a University Hospital in Latin America
    Sua, Luz F.
    Rodriguez, Lisa X.
    Fernandez, Liliana
    Munoz, Carlos A.
    Restrepo, Juan G.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S591 - S592
  • [34] Epidermal growth factor receptor tyrosine kinase inhibitor in treatment of brain metastasis from non-small cell lung cancer
    Zhang, Lan-jun
    Cai, Ling
    Zhu, Jian-fei
    Rong, Tie-hua
    Wu, Shao-xiong
    Chen, Zhong-pin
    Liu, Meng-zhong
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
    Cascone, T
    Morelli, MP
    Ciardiello, F
    ANNALS OF ONCOLOGY, 2006, 17 : 46 - 48
  • [36] Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer
    Steins, Martin B.
    Reinmuth, Niels
    Bischoff, Helge
    Kindermann, Markus
    Thomas, Michael
    ONKOLOGIE, 2010, 33 (12): : 704 - 709
  • [37] Targeting the epidermal growth factor receptor in non-small cell lung cancer
    Herbst, RS
    Bunn, PA
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 5813 - 5824
  • [38] Epidermal growth factor receptor inhibitors in non-small cell lung cancer
    Dancey, Janet E.
    DRUGS, 2007, 67 (08) : 1125 - 1138
  • [39] Epidermal growth factor receptor inhibition and non-small cell lung cancer
    von Eyben, Finn Edler
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2006, 43 (04) : 291 - 323
  • [40] Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
    Janet E. Dancey
    Drugs, 2007, 67 : 1125 - 1138